Cell-to-cell spread of vaccinia virus is promoted by TGF-β-independent Smad4 signalling

Cell Microbiol. 2020 Aug;22(8):e13206. doi: 10.1111/cmi.13206. Epub 2020 Apr 28.

Abstract

The induction of Smad signalling by the extracellular ligand TGF-β promotes tissue plasticity and cell migration in developmental and pathological contexts. Here, we show that vaccinia virus (VACV) stimulates the activity of Smad transcription factors and expression of TGF-β/Smad-responsive genes at the transcript and protein levels. Accordingly, infected cells share characteristics to those undergoing TGF-β/Smad-mediated epithelial-to-mesenchymal transition (EMT). Depletion of the Smad4 protein, a common mediator of TGF-β signalling, results in an attenuation of viral cell-to-cell spread and reduced motility of infected cells. VACV induction of TGF-β/Smad-responsive gene expression does not require the TGF-β ligand or type I and type II TGF-β receptors, suggesting a novel, non-canonical Smad signalling pathway. Additionally, the spread of ectromelia virus, a related orthopoxvirus that does not activate a TGF-β/Smad response, is enhanced by the addition of exogenous TGF-β. Together, our results indicate that VACV orchestrates a TGF-β-like response via a unique activation mechanism to enhance cell migration and promote virus spread.

Keywords: PAI-1; Smad4; TGF-β; cell migration; vaccinia virus.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line, Tumor
  • Cell Movement / drug effects
  • Epithelial-Mesenchymal Transition
  • HT29 Cells
  • HaCaT Cells
  • HeLa Cells
  • Humans
  • Signal Transduction*
  • Smad4 Protein / genetics*
  • Smad4 Protein / metabolism*
  • Transforming Growth Factor beta / genetics
  • Transforming Growth Factor beta / metabolism*
  • Transforming Growth Factor beta / pharmacology
  • Vaccinia virus / drug effects
  • Vaccinia virus / physiology*

Substances

  • SMAD4 protein, human
  • Smad4 Protein
  • Transforming Growth Factor beta